LEADER 01314nam  2200373 a 450 
001 9910701971803321
005 20120711072001.0
035   $a(CKB)5470000002422398
035   $a(OCoLC)798803122
035   $a(EXLCZ)995470000002422398
100   $a20120711d2012      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPrescription drugs$b[electronic resource] $eFDA has met most performance goals for reviewing applications : report to congressional requesters
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2012]
215   $a1 online resource (iii, 46 pages) $cillustrations
300   $aTitle from PDF title screen (viewed July 10, 2012).
300   $a"March 2012."
300   $a"GAO-12-500."
320   $aIncludes bibliographical references.
517   $aPrescription drugs 
606   $aDrug approval$xEconomic aspects$zUnited States
606   $aPharmaceutical industry$xEconomic aspects$zUnited States
615  0$aDrug approval$xEconomic aspects
615  0$aPharmaceutical industry$xEconomic aspects
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910701971803321
996   $aPrescription drugs$92884258
997   $aUNINA